Meanwhile, the company also launched its Rozebalamin (ultra-high-dose mecobalamin) vitamin B12 product for slowing the progression of functional impairment in amyotrophic lateral sclerosis (ALS ...

Others include Amgen's Tepezza (tezepelumab) for thyroid eye disease, Takeda's Fruzaqla (fruquintinib) for advanced colorectal cancer, Eisai's Rozebalamin (mecobalamin) for amyotrophic lateral ...